Phase Ia/Ib Chemo-Radiation Trial of Gemcitabine and Dose-Escalated Thoracic Radiation in Patients with Stage III A/B Non-small Cell Lung Cancer

This publication has 30 references indexed in Scilit:

• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431
  Journal of Clinical Oncology, 2002
• Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
  Cancer, 2001
• A phase I–II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients
  Annals of Oncology, 2000
• Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 1999
• Phase I study concomitant gemcitabine (G) with radiotherapy (RT) in stage III NSCLC
  European Journal Of Cancer, 1999
• Book review
  Published by Elsevier ,1998
• 141 Gemcitabine: In vitro and in vivo evidence of its radiation sensitizing activity and studies using fluorine-19 magnetic resonance spectroscopy to determine an optimal gemcitabine dosing schedule - pre-clinical observations relevant to gemcitabine clinical trials
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
  European Journal Of Cancer, 1996
• The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer
  British Journal of Cancer, 1993